ARTICLE | Clinical News
MSI-78: Commencing Phase IIB/III clinical trial
April 26, 1993 7:00 AM UTC
Magainin Pharmaceuticals Inc. (MAGN) Product: MSI-78 Indication: Topical treatment of impetigo Status: Commencing Phase IIB/III clinical trial this summer ...